A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)

AJ Scott, AB Mallick, E Dotan, SJ Cohen, PJ Gold, HS Hochster, S Subramaniam, A Barzi, GS Watts, PJ Blatchford, WA Messersmith

Research output: Contribution to conferencePaperpeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science